Cargando…

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design

To better understand how inhibition of the influenza neuraminidase (NA) protein contributes to protection against influenza, we produced lentiviral vectors pseudotyped with an avian H11 hemagglutinin (HA) and the NA of all influenza A (N1–N9) subtypes and influenza B (B/Victoria and B/Yamagata). The...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Costa, Kelly A. S., Del Rosario, Joanne Marie M., Ferrari, Matteo, Vishwanath, Sneha, Asbach, Benedikt, Kinsley, Rebecca, Wagner, Ralf, Heeney, Jonathan L., Carnell, George W., Temperton, Nigel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571397/ https://www.ncbi.nlm.nih.gov/pubmed/36146598 http://dx.doi.org/10.3390/vaccines10091520

Ejemplares similares

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection
por: Del Rosario, Joanne Marie M., et al.
Publicado: (2021)

Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014
por: Seleka, Mpho, et al.
Publicado: (2017)

The Epidemiology and Burden of Influenza B/Victoria and B/Yamagata Lineages in Kenya, 2012–2016
por: Emukule, Gideon O, et al.
Publicado: (2019)

The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21(st) century
por: Caini, Saverio, et al.
Publicado: (2019)

The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
por: Scott, Simon D., et al.
Publicado: (2016)

Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages
por: Nakauchi, Mina, et al.
Publicado: (2014)

Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies
por: Ferrara, Francesca, et al.
Publicado: (2021)

Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
por: Carnell, George William, et al.
Publicado: (2015)

Co-circulation of influenza A(H1N1), A(H3N2), B(Yamagata) and B(Victoria) during the 2017−2018 influenza season in Zhejiang Province, China
por: Mao, Haiyan, et al.
Publicado: (2020)

Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines
por: Carnell, George W., et al.
Publicado: (2021)

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
por: Kiseleva, Irina, et al.
Publicado: (2018)

Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
por: Ferrara, Francesca, et al.
Publicado: (2016)

The use of equine influenza pseudotypes for serological screening
por: Scott, Simon, et al.
Publicado: (2012)

Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?
por: Paget, John, et al.
Publicado: (2022)

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance
por: Skowronski, Danuta M., et al.
Publicado: (2012)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
por: Kinsley, Rebecca, et al.
Publicado: (2020)

Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season
por: Korsun, N. S., et al.
Publicado: (2019)

Extinction of the Influenza B Yamagata Line during the COVID Pandemic—Implications for Vaccine Composition
por: Vajo, Zoltan, et al.
Publicado: (2022)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria- and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs
por: Saim-Mamoun, Amel, et al.
Publicado: (2023)

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays
por: Ferrara, Francesca, et al.
Publicado: (2017)

The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection-Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures
por: Wilson, Jo L., et al.
Publicado: (2023)

The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures
por: Wilson, Jo L., et al.
Publicado: (2023)

Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011−12 Season
por: Lo, Yi-Chun, et al.
Publicado: (2013)

Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses
por: Sampson, Alexander Thomas, et al.
Publicado: (2021)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
por: Abed, Yacine, et al.
Publicado: (2019)

The first epidemiological and virological influenza surveillance in the Republic of Guinea revealed the predominance of influenza A/H3N2 and B Victoria viruses
por: Keita, Mamadou Bhoye, et al.
Publicado: (2021)

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Vaccine Mismatches, Viral Circulation, and Clinical Severity Patterns of Influenza B Victoria and Yamagata Infections in Brazil over the Decade 2010–2020: A Statistical and Phylogeny–Trait Analyses
por: da Costa, Jaline Cabral, et al.
Publicado: (2022)

Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2022)

The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses
por: Molesti, Eleonora, et al.
Publicado: (2013)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
por: Ramage, Walter, et al.
Publicado: (2019)

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses†
por: Oakley, Aaron J., et al.
Publicado: (2010)

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility
por: Farrukee, R., et al.
Publicado: (2018)

Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase
por: Tsai, Cheguo, et al.
Publicado: (2009)

The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes
por: Ferrara, Francesca, et al.
Publicado: (2013)

Expanding Mouse-Adapted Yamagata-like Influenza B Viruses in Eggs Enhances In Vivo Lethality in BALB/c Mice
por: Pekarek, Matthew J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ag5t5vbqtnako4ntrfh2jvagsh